Scientists have developed a promising new cancer therapy using specially engineered natural killer cells that can slip past the immune system's defenses to destroy tumors with precision.

The treatment, called CAR-NK cell therapy, works by equipping immune cells with synthetic receptors designed to target cancer cells directly. While similar CAR-T therapies have already been approved to treat blood cancers like leukemia and lymphoma, this CAR-NK approach remains in clinical trials and represents an exciting frontier in personalized medicine. The key advantage: these natural killer cells can evade immune rejection in ways that make them potentially more versatile for treating a wider range of cancers. Read the full story →

Today's takeaway: This innovative cell therapy could transform cancer treatment by overcoming one of medicine's toughest barriers—getting custom-built immune cells to do their job without being rejected.